Girish Mahajan (Editor)

European Society for Medical Oncology

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Membership  15,000
Staff  75
Official language  English
Headquarters  Lugano, Switzerland
European Society for Medical Oncology httpsmedialicdncommprmprshrink200200AAE


Photos from the european society for medical oncology congress

European society for medical oncology esmo guideline app

About ESMO

The European Society for Medical Oncology (ESMO) is a non-profit professional medical oncology society in Europe.


ESMO offers post-graduate education and training in clinical cancer care and research, and produces evidence-based recommendations for basic standards of cancer care. While the majority of ESMO's 15,000 members are medical oncologists, actual membership spans over 130 countries and also includes radiation and surgical oncologists, as well as other oncology healthcare professionals actively involved in cancer treatment, research, and patient care.

Founded in 1975 by Georges Mathé and Maurice Schneider, in Nice, France, as the Société de Médicine Interne Cancérologique, ESMO took on its present name in 1980.

ESMO's Mission

  • To improve the quality of prevention, diagnosis, treatment, supportive and palliative care, as well as the follow-up of patients with malignant disorders
  • To advance the art, science, recognition, and practice of oncology
  • To disseminate knowledge in oncology to cancer patients and the public
  • To educate and train persons involved in clinical cancer care and research
  • To promote education in oncology in order to ensure a high standard of qualification of medical oncologists within the multidisciplinary team
  • To facilitate equal access to optimal cancer care to all cancer patients
  • To maintain liaisons with other oncology specialties, cancer leagues, universities, patient groups and, where appropriate, the pharmaceutical industry
  • Annals of Oncology

    Founded in 1990, ESMO’s flagship scientific journal, Annals of Oncology, publishes articles addressing medical oncology, surgery, radiotherapy, pediatric oncology, basic research and the comprehensive management of patients with malignant diseases. Annals of Oncology is the official journal of ESMO and from 2008 of the Japanese Society for Medical Oncology (JSMO)

    ESMO Clinical Practice Guidelines

    The ESMO Clinical Practice Guidelines (CPG) are intended to provide oncology professionals with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine. Each Clinical Practice Guideline includes information on the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up designed to help oncologists deliver an appropriate quality of care to their patients.

  • Breast Cancer
  • Cancers of Unknown Primary Site
  • ESMO CNS Malignancies
  • ESMO Endocrine Cancers
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Gynaecological Cancers
  • Head and Neck Cancers
  • Haematological Malignancies
  • Lung Cancer
  • Melanoma
  • Neuroendocrine Tumours
  • Sarcoma and GIST
  • Supportive Care
  • ESMO Conferences

    The annual ESMO Congress, held every second year in joint partnership with the European CanCer Organisation (ECCO) is attended by 15,000 participants. The congress presents the latest scientific developments in basic, translational and clinical cancer research and contextualizes new findings for practical implementation in every day patient care.

    Together with other European oncology societies, ESMO organizes conferences in its four core specialty areas of breast cancer, gastrointestinal cancer, genitourinary cancer and lung cancer. ESMO also organizes educational symposia on innovative topics in oncology. In addition ESMO provides faculty speakers and accredits high quality oncology events with the ESMO Label.

    ESMO holds Patient Seminars within its annual meeting for cancer patients, their families and caregivers.


    European Society for Medical Oncology Wikipedia